Intro
Preface
Contents
Editors and Contributors
1: Introduction to Lung Disease
1.1 Introduction
1.2 Overview of Lung Disease
1.2.1 Chronic Obstructive Pulmonary Disease
1.2.1.1 Etiology
1.2.1.2 The Genetic Origins
1.2.1.3 MicroRNAs ́Origins
1.2.1.4 Pathophysiology
1.2.1.5 Treatment
1.2.2 Asthma
1.2.2.1 Etiology
1.2.2.2 Epidemiology (Hernandez-Gonzalez et al. 2021
Hoffman 2021)
1.2.2.3 Pathophysiology
1.2.2.4 Treatment
1.2.3 Pneumonia
1.2.3.1 Etiology
1.2.3.2 Epidemiology
1.2.3.3 Pathophysiology
1.2.3.4 Treatment

1.2.4 Tuberculosis
1.2.4.1 Etiology
1.2.4.2 Epidemiology
1.2.4.3 Pathophysiology
1.2.4.4 Treatment
1.2.5 Cystic Fibrosis
1.2.5.1 Etiology
1.2.5.2 Epidemiology
1.2.5.3 Pathophysiology
1.2.5.4 Treatment
1.2.6 Lung Cancer
1.2.6.1 Etiology
1.2.6.2 Epidemiology
1.2.6.3 Pathophysiology
1.2.6.4 Treatment
1.3 Conclusion
References
2: Natural Polymers for Drugs Delivery
2.1 Introduction
2.2 Polysaccharide-Based Drug Delivery Systems
2.2.1 Alginate-Based Drug Delivery Systems
2.2.2 Cyclodextrin-Based Drug Delivery Systems

2.2.3 Chitosan-Based Drug Delivery Systems
2.2.4 Dextran-Based Drug Delivery Systems
2.2.5 Agarose-Based Drug Delivery Systems
2.2.6 Hyaluronic Acid-Based Drug Delivery Systems
2.2.7 Starch-Based Drug Delivery Systems
2.2.8 Cellulose-Based Drug Delivery Systems
2.3 Protein-Based Drug Delivery Systems
2.3.1 Collagen-Based DDS
2.3.2 Albumin and Gelatin-Based Drug Delivery Systems
2.4 Summary and Conclusion
References
3: Drug Delivery Systems Based on Various Natural Polymers for Lung Diseases
3.1 Introduction
3.2 Merits of Natural Polymers

3.3 Demerits of Natural Polymers
3.4 Natural Polymer-Based Drug Delivery Systems for Lung Disease
3.4.1 Polymeric Nanoparticles
3.4.2 Nanocrystals
3.4.3 Polymeric Microparticles
3.4.4 Pulsatile Microcapsules
3.4.5 Liposomes
3.4.6 Microspheres
3.4.7 Nanospheres
3.4.8 Polymeric Solutions
3.4.9 Nanofibers
3.5 Devices for Delivery of Drugs
3.5.1 Dry Powder Inhalers
3.5.2 Nebulizers
3.5.3 Metered Dose Inhalers
3.6 Advantages of Natural Polymers in Developing Drug Delivery System for Lung Diseases
3.7 Conclusion
References

Part I: Plant-Derived Natural Polymers Employed in Respiratory Diseases
4: Cellulose-Based Drug Delivery Systems in Lung Disorders
4.1 Introduction
4.2 Characteristics of Cellulose
4.3 Global Production of Cellulose
4.4 Application of Cellulose and its Derivatives in Lung Diseases
4.4.1 Cellulose and Lung Cancer
4.4.2 Cellulose and Lung Infections
4.4.3 Cellulose and Influenza
4.4.4 Cellulose and Tuberculosis
4.4.5 Cellulose and Lung Tissue Engineering
4.4.6 Cellulose and Chronic Obstructive Pulmonary Disease
4.4.7 Cellulose and Asthma